2018
Immunological differences between primary and metastatic breast cancer
Szekely B, Bossuyt V, Li X, Wali VB, Patwardhan GA, Frederick C, Silber A, Park T, Harigopal M, Pelekanou V, Zhang M, Yan Q, Rimm DL, Bianchini G, Hatzis C, Pusztai L. Immunological differences between primary and metastatic breast cancer. Annals Of Oncology 2018, 29: 2232-2239. PMID: 30203045, DOI: 10.1093/annonc/mdy399.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAntineoplastic Agents, ImmunologicalB7-H1 AntigenBiomarkers, TumorBiopsyBreast NeoplasmsDisease ProgressionDrug Resistance, NeoplasmFemaleGene Expression RegulationHumansImmunologic SurveillanceLymphocyte CountLymphocytes, Tumor-InfiltratingMiddle AgedMutation RateTumor EscapeTumor MicroenvironmentYoung AdultConceptsMetastatic breast cancerBreast cancerTherapeutic targetToll-like receptor pathway genesImmuno-oncology therapeutic targetsBreast cancer evolvesImmune proteasome expressionPD-L1 positivityCorresponding primary tumorsPotential therapeutic targetMHC class IImmune-related genesMetastatic cancer samplesLigand/receptor pairLymphocyte countT helperT-regsPD-L1Immune microenvironmentCytotoxic TPrimary tumorMastoid cellsDisease progressionTherapeutic combinationsMacrophage markers
2011
Comparison of Affirm VPIII and Papanicolaou Tests in the Detection of Infectious Vaginitis
Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC. Comparison of Affirm VPIII and Papanicolaou Tests in the Detection of Infectious Vaginitis. American Journal Of Clinical Pathology 2011, 135: 442-447. PMID: 21350100, DOI: 10.1309/ajcp7tbn5vzuglzu.Peer-Reviewed Original ResearchConceptsAffirm VPIIIPap testPapanicolaou testRoutine Pap testRoutine Papanicolaou testCandida speciesSensitive diagnostic testInfectious vaginitisLarge academic institutionPatient populationTrichomonas infectionBacterial vaginosisCandida vaginitisG vaginalisT vaginalisStudy populationHigh incidenceDiagnostic testsMolecular testsPatientsVaginitisVaginalisMorphologic identificationVaginosisCandidiasis
2004
Comparison of human papillomavirus DNA prevalence in atypical squamous cells of undetermined significance subcategories as defined by the original Bethesda 1991 and the new Bethesda 2001 Systems.
Pirog EC, Erroll M, Harigopal M, Centeno BA. Comparison of human papillomavirus DNA prevalence in atypical squamous cells of undetermined significance subcategories as defined by the original Bethesda 1991 and the new Bethesda 2001 Systems. Archives Of Pathology & Laboratory Medicine 2004, 128: 527-32. PMID: 15086283, DOI: 10.5858/2004-128-527-cohpdp.Peer-Reviewed Original ResearchConceptsAtypical squamous cellsHigh-grade squamous intraepithelial lesionsTBS 2001Squamous intraepithelial lesionsSquamous cellsASCUS casesIntraepithelial lesionsIndividual morphologic featuresMorphologic featuresHPV DNAHPV detectionPap testAtypical cellsUndetermined significanceBroad-spectrum HPV DNA amplificationControl groupHuman papillomavirus (HPV) DNA prevalenceASC-H casesBethesda 2001 systemPrevalence of HPVThinPrep Pap testsHPV DNA amplificationHuman papillomavirus DNAPanel of pathologistsBethesda System 2001
2003
Secondary tumors in mammary adenolipomas: a report of 2 unusual cases.
Harigopal M, Mudrovich SA, Hoda SA, Rosen PP. Secondary tumors in mammary adenolipomas: a report of 2 unusual cases. Archives Of Pathology & Laboratory Medicine 2003, 127: e151-4. PMID: 12653605, DOI: 10.5858/2003-127-e151-stimaa.Peer-Reviewed Original ResearchMeSH KeywordsAdenomaAdolescentAdultBreast NeoplasmsFemaleFibroadenomaHumansLipomaNeoplasms, Second PrimaryConceptsSecondary tumorsDuct epithelial hyperplasiaAtypical lobular hyperplasiaCyst-lining epitheliumLobular hyperplasiaRecent pregnancyRight breastPostpartum periodAsymmetric enlargementEpithelial hyperplasiaSecondary lesionsLining epitheliumUnusual caseAdenolipomaHyperplasiaFirst caseTumorsSecond caseAdenofibromaInfarctionPregnancyFibroadenomaLesionsBreastCysts